ArticleScientific reports2026
In silico study of 14-3-3σ and Nipah virus W proteins interaction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nipah virus (NiV) is a highly pathogenic zoonotic RNA virus that causes severe encephalitis, systemic vasculitis, and multiorgan damage in humans, with a case fatality rate of 40-75%. Among the viral factors implicated in NiV pathogenicity is the W protein, an intrinsically disordered product of the P gene. By binding to members of the 14-3-3 protein family, which regulate critical processes such as the cell cycle, apoptosis, and immune responses, W protein is thought to modulate host signaling pathways. Yet the molecular and structural basis of this interaction remains poorly understood. Here, we employed the AlphaFold 3 algorithm to predict 1000 models of the heterotetrameric complex formed by W protein dimers and the 14-3-3σ dimer. Candidate structures were filtered according to two structural criteria-potential disulfide bond formation between Cys421 residues of the W dimer, and preservation of interactions between phosphorylated Ser449 (Sep449) and residues Arg56, Arg129, and Tyr130 in the 14-3-3σ binding site. Nine models that satisfied these criteria were further refined and evaluated by molecular dynamics (MD) simulations in the OpenMM environment. Following 100-ns MD simulations, three models were selected for extended microsecond-scale simulations to assess their stability over extended timescales. The simulations indicated that all three complexes remained stable over the simulated timescales and displayed structural features consistent with interactions involving intrinsically disordered proteins. Among them, one model (Model 3) showed the most favorable combination of structural and energetic features. Our findings support the structural feasibility of the proposed interaction and demonstrate that the modeled heterotetrameric complex is capable of adopting stable conformations. These results provide a basis for further in silico studies and exploratory small-molecule screening aimed at modulating this protein-protein interaction in the context of viral host-pathogen interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.